• Latest Posts

FDA fast track for Memo’s kidney transplant infection treatment

Astellas eyes ophthalmology field with $5.9B Iveric Bio takeover

Schizophrenia injection gets FDA approval

Single-molecule valve breakthrough could lead to early disease diagnosis

Interview 2 May 2023

Generative AI in novel drug development

ADVERTISEMENT

Brenus Pharma reveals ‘groundbreaking’ preclinical results for colorectal cancer and solid tumor drug

Mezzion Pharma raises $40M for treatment option for heart surgery patients

Vitalli Bio formed to focus on immunological disorders

Six synthetic biology companies that have made a mark

ADC firm Adcentrx Therapeutics aims for clinic after $38M boost

Podcast 28 Apr 2023

Beyond Biotech podcast 43

ADVERTISEMENT